PERSPECTA

News from every angle

← Back to headlines

Prime Medicine Stock Slips After Q4 Updates

Prime Medicine's stock experienced a decline following the release of its fourth-quarter updates, indicating investor reaction to the company's latest financial performance or outlook.

3 Mar, 18:22 — 3 Mar, 18:22
PostShare
Only 1 source covers this story